ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,795
0,04%
Bitcoin
66 383,29
-0,83%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AbCellera Biologics Inc (ABCL)

  7. AbCellera Biologics Inc (ABCL) Actualités

ABCL

AbCellera Biologics (ABCL)

AbCellera Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ABCL
DateHeureSourceTitreSymboleSociété
07/05/202422h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
07/05/202422h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
07/05/202422h05Business WireAbCellera Reports Q1 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
01/05/202415h00Business WireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesNASDAQ:ABCLAbCellera Biologics Inc
08/04/202418h05Business WireAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
03/04/202422h05Business WireAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ABCLAbCellera Biologics Inc
19/03/202421h05Business WireAbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024NASDAQ:ABCLAbCellera Biologics Inc
11/03/202414h00Business WireAbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological ConditionsNASDAQ:ABCLAbCellera Biologics Inc
05/03/202422h30Business WireAbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
27/02/202420h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
23/02/202422h30Business WireAbCellera Announces Resignation of Board MemberNASDAQ:ABCLAbCellera Biologics Inc
23/02/202402h15Business WireAbCellera to Present at Upcoming Investor Conferences in MarchNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422h49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422h05Business WireAbCellera Reports Full Year 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
23/01/202422h05Business WireAbCellera to Report Full Year 2023 Financial Results on February 20, 2024NASDAQ:ABCLAbCellera Biologics Inc
20/12/202322h05Business WireAbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
16/11/202322h05Business WireAbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023NASDAQ:ABCLAbCellera Biologics Inc
03/11/202317h05Business WireAbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023NASDAQ:ABCLAbCellera Biologics Inc
02/11/202321h05Business WireAbCellera Reports Q3 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
01/11/202321h05Business WirePrelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in OncologyNASDAQ:ABCLAbCellera Biologics Inc
31/10/202321h05Business WireAbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023NASDAQ:ABCLAbCellera Biologics Inc
11/10/202322h05Business WireAbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:ABCLAbCellera Biologics Inc
27/09/202315h00Business WireAbCellera Announces Two T-Cell Engager Presentations at SITC 2023NASDAQ:ABCLAbCellera Biologics Inc
20/09/202323h02Business WireAbCellera Expands Multi-Target Antibody Discovery Collaboration with RegeneronNASDAQ:ABCLAbCellera Biologics Inc
13/09/202315h00Business WireAbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in OncologyNASDAQ:ABCLAbCellera Biologics Inc
03/08/202322h05Business WireAbCellera Reports Q2 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
24/07/202322h05Business WireAbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for RehearingNASDAQ:ABCLAbCellera Biologics Inc
06/07/202322h05Business WireAbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023NASDAQ:ABCLAbCellera Biologics Inc
30/05/202319h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABCLAbCellera Biologics Inc
29/05/202322h05Business WireAbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023NASDAQ:ABCLAbCellera Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ABCL

Dernières Valeurs Consultées

NASDAQ
IGW
BIT
P1SPG8
BNP Paribas Issuance
LSE
ZQ82
Inter-amer 31
TSX
CPX.PR.C
Capital Power
OKEX
MYRIAUSDT
Myria
LSE
SALU
Etfs Salu
GATE
FEIETH
Fei USD
ASX
PHX
PharmX Technologies
COIN
AG10USD
Agri10x Token
ASX
POEHA
Progress 2023 1
LSE
62CS
Investec Bnk 24
TSXV
CVB
Compass Gold
LSE
65DT
Investec Bnk 24
TG
JT71
Australian Vanadium
BOV
PETRF2
PETRF2 Ex:23,95
LSE
60KF
Investec Bnk 25
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés